J.B.CHEMICALS | PROCTER & GAMBLE HEALTH | J.B.CHEMICALS/ PROCTER & GAMBLE HEALTH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 56.1 | 34.8 | 161.4% | View Chart |
P/BV | x | 12.2 | 10.6 | 115.3% | View Chart |
Dividend Yield | % | 0.5 | 2.0 | 23.9% |
J.B.CHEMICALS PROCTER & GAMBLE HEALTH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
J.B.CHEMICALS Mar-23 |
PROCTER & GAMBLE HEALTH Jun-23 |
J.B.CHEMICALS/ PROCTER & GAMBLE HEALTH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 2,150 | 5,366 | 40.1% | |
Low | Rs | 1,339 | 3,883 | 34.5% | |
Sales per share (Unadj.) | Rs | 407.0 | 740.7 | 54.9% | |
Earnings per share (Unadj.) | Rs | 53.0 | 138.2 | 38.3% | |
Cash flow per share (Unadj.) | Rs | 67.8 | 155.2 | 43.7% | |
Dividends per share (Unadj.) | Rs | 8.88 | 95.00 | 9.3% | |
Avg Dividend yield | % | 0.5 | 2.1 | 24.8% | |
Book value per share (Unadj.) | Rs | 304.8 | 447.6 | 68.1% | |
Shares outstanding (eoy) | m | 77.38 | 16.60 | 466.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 4.3 | 6.2 | 68.7% | |
Avg P/E ratio | x | 32.9 | 33.5 | 98.4% | |
P/CF ratio (eoy) | x | 25.7 | 29.8 | 86.4% | |
Price / Book Value ratio | x | 5.7 | 10.3 | 55.4% | |
Dividend payout | % | 16.7 | 68.7 | 24.4% | |
Avg Mkt Cap | Rs m | 134,983 | 76,761 | 175.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 5,435 | 2,062 | 263.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 31,493 | 12,296 | 256.1% | |
Other income | Rs m | 99 | 184 | 54.1% | |
Total revenues | Rs m | 31,592 | 12,480 | 253.1% | |
Gross profit | Rs m | 6,958 | 3,247 | 214.3% | |
Depreciation | Rs m | 1,144 | 281 | 407.1% | |
Interest | Rs m | 361 | 8 | 4,682.2% | |
Profit before tax | Rs m | 5,552 | 3,142 | 176.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1,452 | 847 | 171.4% | |
Profit after tax | Rs m | 4,100 | 2,295 | 178.7% | |
Gross profit margin | % | 22.1 | 26.4 | 83.7% | |
Effective tax rate | % | 26.2 | 27.0 | 97.0% | |
Net profit margin | % | 13.0 | 18.7 | 69.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 15,993 | 11,713 | 136.5% | |
Current liabilities | Rs m | 6,257 | 6,791 | 92.1% | |
Net working cap to sales | % | 30.9 | 40.0 | 77.2% | |
Current ratio | x | 2.6 | 1.7 | 148.2% | |
Inventory Days | Days | 85 | 263 | 32.4% | |
Debtors Days | Days | 667 | 343 | 194.3% | |
Net fixed assets | Rs m | 24,988 | 10,617 | 235.4% | |
Share capital | Rs m | 155 | 166 | 93.2% | |
"Free" reserves | Rs m | 23,433 | 7,265 | 322.6% | |
Net worth | Rs m | 23,587 | 7,431 | 317.4% | |
Long term debt | Rs m | 3,832 | 0 | - | |
Total assets | Rs m | 40,981 | 22,330 | 183.5% | |
Interest coverage | x | 16.4 | 409.1 | 4.0% | |
Debt to equity ratio | x | 0.2 | 0 | - | |
Sales to assets ratio | x | 0.8 | 0.6 | 139.6% | |
Return on assets | % | 10.9 | 10.3 | 105.6% | |
Return on equity | % | 17.4 | 30.9 | 56.3% | |
Return on capital | % | 21.6 | 42.4 | 50.9% | |
Exports to sales | % | 40.6 | 0 | - | |
Imports to sales | % | 17.5 | 13.1 | 133.8% | |
Exports (fob) | Rs m | 12,784 | NA | - | |
Imports (cif) | Rs m | 5,500 | 1,605 | 342.6% | |
Fx inflow | Rs m | 12,784 | 1,465 | 872.5% | |
Fx outflow | Rs m | 5,500 | 1,605 | 342.6% | |
Net fx | Rs m | 7,284 | -140 | -5,195.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 6,256 | 2,360 | 265.1% | |
From Investments | Rs m | -9,618 | -215 | 4,473.4% | |
From Financial Activity | Rs m | 3,565 | -985 | -362.1% | |
Net Cashflow | Rs m | 204 | 1,160 | 17.6% |
Indian Promoters | % | 0.0 | 0.0 | - | |
Foreign collaborators | % | 53.8 | 51.8 | 103.8% | |
Indian inst/Mut Fund | % | 29.4 | 20.0 | 147.4% | |
FIIs | % | 11.1 | 6.2 | 177.2% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 46.2 | 48.2 | 95.9% | |
Shareholders | 63,892 | 56,778 | 112.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare J.B.CHEMICALS With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | J.B.Chemicals | Procter & Gamble Health | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.82% | 0.18% | 0.97% |
1-Month | 15.17% | -0.72% | 2.08% |
1-Year | 79.67% | -0.85% | 55.37% |
3-Year CAGR | 41.79% | -8.62% | 15.04% |
5-Year CAGR | 60.31% | 5.02% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the J.B.Chemicals share price and the Procter & Gamble Health share price.
Moving on to shareholding structures...
The promoters of J.B.Chemicals hold a 53.8% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of J.B.Chemicals and the shareholding pattern of Procter & Gamble Health.
Finally, a word on dividends...
In the most recent financial year, J.B.Chemicals paid a dividend of Rs 8.9 per share. This amounted to a Dividend Payout ratio of 16.7%.
Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.
You may visit here to review the dividend history of J.B.Chemicals, and the dividend history of Procter & Gamble Health.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended the higher.